Track Piramal Phytocare Ltd's current share price, historical price chart, 52-week high/low, and performance across different time periods.
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Piramal Phytocare Ltd covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Piramal Phytocare Ltd Shareholding Pattern
Quarterly breakdown of Piramal Phytocare Ltd ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Piramal Phytocare Ltd shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Piramal Phytocare Ltd?
The current share price of Piramal Phytocare Ltd is ₹ 22.70 as of 20 Aug 2020.
What is the market capitalisation of Piramal Phytocare Ltd?
The market capitalisation of Piramal Phytocare Ltd stands at -.
What is the PE ratio of Piramal Phytocare Ltd?
The Price-to-Earnings (PE) ratio of Piramal Phytocare Ltd is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Piramal Phytocare Ltd?
Piramal Phytocare Ltd has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of Piramal Phytocare Ltd?
The 52-week high of Piramal Phytocare Ltd is - and the 52-week low is -.
What is the dividend yield of Piramal Phytocare Ltd?
The dividend yield of Piramal Phytocare Ltd is 0.00% based on the current market price.
What is the FII and DII holding in Piramal Phytocare Ltd?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Piramal Phytocare Ltd shares.
What sector does Piramal Phytocare Ltd belong to?
Piramal Phytocare Ltd operates in the Healthcare sector.
What is the beta of Piramal Phytocare Ltd?
The beta of Piramal Phytocare Ltd is 0.09, indicating its price volatility relative to the broader market. Over the past 1 year, Piramal Phytocare Ltd has delivered an absolute return of -4.62%.
What is the RSI of Piramal Phytocare Ltd?
The 14-day Relative Strength Index (RSI) of Piramal Phytocare Ltd is 46.52, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
No corporate action data available.
Company Profile
Overview of Piramal Phytocare Ltd covering business description, industry classification, key management, financial ratios, and listed exchange details.
Piramal Phytocare Limited, formerly Piramal Life Sciences Limited, is engaged in pharmaceutical business. The Company is engaged in the manufacturing and marketing of herbal products and other products. Its medicinal products are made from herbal extracts. It is engaged in global marketing of finished pharmaceutical dosage forms especially Proprietary Formulations, wherein the active ingredients are derived from natural sources. It offers a range of products that are developed to manage lifestyle ailments, such as diabetes, arthritis, obesity, constipation, liver damage, anxiety, sexual dysfunction, cough and cold. Its products include Sleecap capsule, Pylee capsule, Soyaklin forte capsule, Prementrid capsule, Zayata capsule, Rtunorm capsule, Khasceeze syrup, Intelimax capsule, Contudol gel, Phyleclip capsule, Contudol capsule, Sugarcare capsule, Stresscare capsule, Cardiocare capsule, Dormocare capsule, Femincare capsule and Menacare capsule. It is a part of the Piramal Group.
Piramal Phytocare Limited, formerly Piramal Life Sciences Limited, is engaged in pharmaceutical business. The Company is engaged in the manufacturing and marketing of herbal products and other products. Its medicinal products are made from herbal extracts. It is engaged in global marketing of finish...
Key personnel
Mr. Maneesh Sharma
Company Secretary
Mr. Rajesh LaddhaD
Non-Executive Director
Ms. Rashida NajmiD
Non-Executive Director
Mr. N. L. BhatiaD
Non-Executive Independent Director
Shri. Gautam Bhailal DoshiD
Non-Executive Independent Director
Incorporated on
27 Jun 2001
Last Annual
31 Mar 2019
Last Interim
30 Sep 2019
No. of Employees
-
IPO date
-
Free Float
-
Website
Phone no.
+912230818000
Address
Saki Vihar Road, MUMBAI, 400069, India
Dec 2014
Mar 2015
Jun 2015
Sep 2015
Dec 2015
Mar 2016
Jun 2016
Sep 2016
Dec 2016
Mar 2017
Jun 2017
Sep 2017
Dec 2017
Mar 2018
Jun 2018
Sep 2018
Dec 2018
Mar 2019
Jun 2019
Sep 2019
Total Promoter
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
56.08
56.08
56.08
56.08
56.08
56.08
56.08
56.08
Indian Promoter
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
57.54
56.08
56.08
56.08
56.08
56.08
56.08
56.08
56.08
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
4.47
4.47
4.43
4.43
4.43
4.02
4.02
4.02
4.05
4.08
4.06
4.02
4.02
4.02
4.02
4.02
4.02
4.02
4.02
4.01
Mutual Funds / UTI
-
-
-
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
FI/Bank/Insurance
3.37
3.37
3.37
3.37
3.37
3.37
3.37
3.37
3.40
3.44
3.42
3.38
3.38
3.37
3.37
3.37
3.37
3.37
3.37
3.36
Govt
-
-
-
-
-
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
-
-
-
FII
1.09
1.09
1.06
1.06
1.06
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
0.64
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
37.99
37.99
38.03
38.03
38.03
38.45
38.45
38.45
38.41
38.38
38.40
38.44
39.90
39.91
39.91
39.91
39.91
39.91
39.91
39.91
Bodies Corporate
5.71
5.69
5.92
5.34
5.82
3.26
5.21
5.84
3.43
3.25
3.35
3.30
3.30
2.94
2.80
2.79
2.74
2.74
2.69
2.52
Others (incl. Retail)
No. of shareholders
32.28
58,704
32.30
58,249
32.11
58,157
32.69
58,107
32.21
57,744
35.19
54,180
33.24
53,729
32.61
53,119
34.98
53,218
35.13
52,863
35.05
52,247
35.14
51,840
36.60
50,445
36.97
50,291
37.11
49,844
37.12
49,232
37.17
48,812
37.17
48,276
37.22
47,841
37.39
47,504
Net Revenue FY
Not enough data
Profit After Tax FY
Not enough data
ROE FY
Not enough data
EBITDA FY
Not enough data
Stock Analysis
Fundamental analysis overview of Piramal Phytocare Ltd covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Earnings yield of nan% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis